These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 12483364
1. Bilateral adrenal swelling as a cause of chest, back, and upper abdominal pain in essential thrombocythemia and polycythemia vera is due to microvascular ischemic thrombosis rather than to hemorrhage. Michiels JJ, Berneman Z, Schroyens W, Krestin GP. Ann Hematol; 2002 Dec; 81(12):691-4. PubMed ID: 12483364 [Abstract] [Full Text] [Related]
2. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, Neumann HA, van Vliet HH. Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481 [Abstract] [Full Text] [Related]
3. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications. Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W. Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274 [Abstract] [Full Text] [Related]
4. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH. Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569 [Abstract] [Full Text] [Related]
5. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T, GIMEMA CMD-Working Party. Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279 [Abstract] [Full Text] [Related]
6. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera. Michiels JJ, Berneman ZN, Schroyens W, Van Vliet HH. Platelets; 2004 Mar; 15(2):67-84. PubMed ID: 15154599 [Abstract] [Full Text] [Related]
7. [What vascular events suggest a myeloproliferative disorder?]. Hachulla E, Rose C, Trillot N, Caulier-Leleu MT, Pasturel-Michon U. J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402 [Abstract] [Full Text] [Related]
8. Severe chest and back pain and bilateral massive adrenal swelling in polycythemia vera: an uncommon case after esophagectomy. Fernández AB, De Avila AS, Gómez N. Minerva Anestesiol; 2012 Dec; 78(12):1416-7. PubMed ID: 22643542 [No Abstract] [Full Text] [Related]
9. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia. Michiels JJ, Berneman Z, Schroyens W, van Urk H. Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947 [Abstract] [Full Text] [Related]
10. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia. Randi ML, Fabris F, Ruzzon E, Pacquola E, Cella G, Girolami A. Haematologica; 2002 Nov; 87(11):1180-4. PubMed ID: 12414348 [Abstract] [Full Text] [Related]
11. Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia. Cucuianu A, Stoia M, Farcaş A, Dima D, Zdrenghea M, Paţiu M, Olinic D, Petrov L. Rom J Intern Med; 2006 Nov; 44(4):397-406. PubMed ID: 18386616 [Abstract] [Full Text] [Related]
12. Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin. Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, van Vliet HH. Blood Cells Mol Dis; 2006 Nov; 36(2):199-205. PubMed ID: 16510297 [Abstract] [Full Text] [Related]
13. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention. Landolfi R, Cipriani MC, Novarese L. Best Pract Res Clin Haematol; 2006 Nov; 19(3):617-33. PubMed ID: 16781491 [Abstract] [Full Text] [Related]
14. Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils. Falanga A, Marchetti M, Barbui T, Smith CW. Semin Hematol; 2005 Oct; 42(4):239-47. PubMed ID: 16210037 [Abstract] [Full Text] [Related]
15. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies. Landolfi R, Di Gennaro L, Novarese L, Patrono C. Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279 [Abstract] [Full Text] [Related]
16. Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera. van Genderen PJ, Michiels JJ. Semin Thromb Hemost; 1997 Apr; 23(4):357-63. PubMed ID: 9263352 [Abstract] [Full Text] [Related]
18. Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk. Barbui T, Finazzi G. Semin Thromb Hemost; 2007 Jun; 33(4):321-9. PubMed ID: 17525889 [Abstract] [Full Text] [Related]
20. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Passamonti F, Rumi E, Pungolino E, Malabarba L, Bertazzoni P, Valentini M, Orlandi E, Arcaini L, Brusamolino E, Pascutto C, Cazzola M, Morra E, Lazzarino M. Am J Med; 2004 Nov 15; 117(10):755-61. PubMed ID: 15541325 [Abstract] [Full Text] [Related] Page: [Next] [New Search]